Name
CitoMed OÜ
Registry code
12797015
Type
OÜ - Limited Liability Company
Status
Bankrupt
Foundation date
09.02.2015 (9)
Financial year
01.01-31.12
Capital
2 500.00 €
Activity
86909 - Other healthcare activities not classified elsewhere 86903 - Provision of nursing care
51 317 €
-10 547 €
-21%
1 014 €
(estimate is approximate)
-20 175 €
3
Submitted
16 282 €
52%
-82%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Darja Belova 13.04.1984 (40) | 51% - 1 275.00 EUR | - | - | |
| Mirjam Luik 01.07.1987 (37) | 49% - 1 225.00 EUR | - | - | |
| Ly Müürsoo 22.08.1962 (62) | - | Bankruptcy trustee | Other control or influence (contractual, family or other relationships) | |
| Kaupo Meier 05.04.1968 (56) | - | Liquidator | - | |
| Mikk Tarraste 13.02.1988 (36) | - | - | - | Founder |
| 2019 23.09.2020 | 2020 28.03.2021 | 2021 24.11.2022 | 2022 30.06.2023 | 2023 19.07.2023 | |
|---|---|---|---|---|---|
| Total Revenue | 196 715 € | 252 250 € | 453 957 € | 155 593 € | 51 317 € |
| Net profit (loss) for the period | 1 651 € | -17 067 € | -14 365 € | 2 153 € | -10 547 € |
| Profit Margin | 1% | -7% | -3% | 1% | -21% |
| Current Assets | 38 282 € | 34 882 € | 78 142 € | 30 528 € | 12 938 € |
| Fixed Assets | 0 € | 1 727 € | 0 € | - | - |
| Total Assets | 38 282 € | 36 609 € | 78 142 € | 30 528 € | 12 938 € |
| Current Liabilities | 18 632 € | 33 708 € | 69 333 € | 40 156 € | 33 113 € |
| Non Current Liabilities | 0 € | 318 € | 20 591 € | 0 € | - |
| Total Liabilities | - | 34 026 € | 89 924 € | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 19 650 € | 2 583 € | -11 782 € | -9 628 € | -20 175 € |
| Employees | 0 | 19 | 10 | 4 | 3 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2023 Q2 | - | 8 537.04 € | 8 935.55 € | 10 |
| 2023 Q1 | - | 13 799.32 € | 14 418.23 € | 10 |
| 2022 Q4 | - | 13 761.28 € | 15 034.94 € | 9 |
| 2022 Q3 | - | 16 087.67 € | 16 813.62 € | 11 |
| 2022 Q2 | - | 14 189.27 € | 14 822.08 € | 10 |
| 2022 Q1 | - | 28 428.24 € | 30 100.16 € | 12 |
| 2021 Q4 | - | 11 913.73 € | 13 286.33 € | 21 |
| 2021 Q3 | - | 28 543.67 € | 30 525.34 € | 25 |
| 2021 Q2 | - | 23 997.7 € | 25 647.42 € | 23 |
| 2021 Q1 | - | 15 821.68 € | 16 770.29 € | 22 |
| 2020 Q4 | - | 27 317.74 € | 29 069.08 € | 13 |
| 2020 Q3 | - | 12 744.8 € | 13 640.64 € | 16 |
| 2020 Q2 | - | 18 672.66 € | 19 872.47 € | 18 |
| 2020 Q1 | - | 14 149.78 € | 15 121.79 € | 18 |
